Elevated NNMT activity has been linked to metabolic inefficiencies, increased fat accumulation, and obesity (1)
Animal experiments have not shown significant adverse effects at therapeutic dosages
The focus shifts from managing symptoms to optimizing health, preserving muscle, supporting micronutrients, preventing complications
Standard dosing ranges from 0.25 to 0.5 mg daily, while micro-dosing protocols typically use 0.1 to 0.15 mg injected subcutaneously once or twice daily
In summary, through the engineering of artificially selected macrocycles, we have developed agonists of a receptor-mediated signalling cascade, opening a unique opportunity to develop non-protein regenerative medicines
In addition, it is crucial for the functioning of the central nervous system, along with the absorption and metabolism of fats and carbohydrates